Cotización Entrada Therapeutics - TRDA

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

20.238

Postura de Compra

20.23

Postura de Venta

20.29

Volume Operado de la Acción

82,332

19.98 Rango del Día 20.50

11.35 Rango de 52 semanas 20.50

Capitalización de Mercado [m]

757.305M

Precio Anterior

20.32

Precio de Apertura

20.32

Hora

20.2397

Última hora de negociación

12:42:02

Volumen financiero

US$ 1,662,845

Precio Promedio Ponderado

20.1968

Volumen promedio (3 m)

135,961

Acciones en circulación

37,419,975

Rendimiento del Dividendo

Ratio Precio/Utilidad

-113.10

Beneficio por acción (BPA)

-0.18

turnover

129.01M

Beneficio neto

-6.69M

Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, an... Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.entradatx.com

Sede

Wilmington, Delaware, USA

Fundado

Entrada Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TRDA. The last closing price for Entrada Therapeutics was US$20.32. Over the last year, Entrada Therapeutics shares have traded in a share price range of US$ 11.35 to US$ 20.50.

Entrada Therapeutics currently has 37,419,975 shares in issue. The market capitalisation of Entrada Therapeutics is US$760.37 million. Entrada Therapeutics has a price to earnings ratio (PE ratio) of -113.10.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	1.258	6.62802950474	18.98	20.5	18.8116	117468	19.9236037	CS
4	2.188	12.1218836565	18.05	20.5	17.09	145331	19.15480753	CS
12	5.228	34.8301132578	15.01	20.5	13.46	135961	17.1199454	CS
26	4.418	27.9266750948	15.82	20.5	13.46	127605	16.58923018	CS
52	6.858	51.2556053812	13.38	20.5	11.35	103467	15.63318042	CS
156	-8.492	-29.5579533589	28.73	29.99	5.12	89235	14.3927171	CS
260	-6.262	-23.6301886792	26.5	36.85	5.12	93598	15.45915206	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CTNTCheetah Net Supply Chain Service Inc	US$ 5.53 (195.72%)	107.05M
ZJKZJK Industrial Company Ltd	US$ 15.01 (136.75%)	20.23M
GWAVGreenwave Technology Solutions Inc	US$ 0.649325 (77.90%)	389.87M
JANXJanux Therapeutics Inc	US$ 62.685 (56.01%)	5.24M
JYDJayud Global Logistics Ltd	US$ 1.0411 (55.36%)	9.16M
REVBRevelation Biosciences Inc	US$ 0.5315 (-44.05%)	3.79M
STSSSharps Technology Inc	US$ 2.13 (-36.49%)	361.44k
OMEXOdyssey Marine Exploration Inc	US$ 0.4912 (-34.08%)	3.47M
GELSGelteq Ltd	US$ 2.703 (-29.25%)	224.91k
CYCNCyclerion Therapeutics Inc	US$ 1.67 (-28.63%)	259.85k
GWAVGreenwave Technology Solutions Inc	US$ 0.649325 (77.90%)	389.93M
SMCISuper Micro Computer Inc	US$ 41.2199 (-1.86%)	167.58M
CTNTCheetah Net Supply Chain Service Inc	US$ 5.53 (195.72%)	108.6M
CHRSCoherus BioSciences Inc	US$ 1.9299 (40.87%)	101.99M
NVDANVIDIA Corporation	US$ 139.30 (0.48%)	99.05M